GLOBAL LONGITUDINAL STRAIN ABNORMAL

GLOBAL LONGITUDINAL STRAIN ABNORMAL was reported 55 times

GLOBAL LONGITUDINAL STRAIN ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cardiac Myosin Inhibitor [EPC] 2 0.0003
1 Progesterone [EPC] 3 0.0001
2 Proteasome Inhibitor [EPC] 14 0.0001
3 Interleukin-1 Receptor Antagonist [EPC] 2 0.0001
4 Sigma-1 Agonist [EPC] 1 0.0001
5 HER2/neu Receptor Antagonist [EPC] 8 0.0001
6 Estrogen Receptor Antagonist [EPC] 2 0.0000
7 Microtubule Inhibitor [EPC] 7 0.0000
8 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 4 0.0000
9 Topoisomerase Inhibitor [EPC] 2 0.0000
10 Aldosterone Antagonist [EPC] 4 0.0000
11 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
12 5-alpha Reductase Inhibitor [EPC] 2 0.0000
13 Aromatase Inhibitor [EPC] 2 0.0000
14 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
15 Estrogen [EPC] 3 0.0000
16 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
17 Alkylating Drug [EPC] 3 0.0000
18 Nitrate Vasodilator [EPC] 1 0.0000
19 Platinum-based Drug [EPC] 3 0.0000
20 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
21 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
22 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
23 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
24 Loop Diuretic [EPC] 4 0.0000
25 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
26 Factor Xa Inhibitor [EPC] 2 0.0000
27 alpha-Adrenergic Blocker [EPC] 1 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
30 Platelet Aggregation Inhibitor [EPC] 3 0.0000
31 RANK Ligand Inhibitor [EPC] 1 0.0000
32 Thiazide Diuretic [EPC] 1 0.0000
33 Atypical Antipsychotic [EPC] 2 0.0000
34 Corticosteroid [EPC] 5 0.0000
35 beta-Adrenergic Blocker [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
37 Kinase Inhibitor [EPC] 1 0.0000